In previous studies (1, 2, 3), we assessed the 9-adrenergic blocking activity of 11 com pounds against the positive chronotropic and inotropic effect of norepinephrine in the isolated and blood-perfused canine sino-atrial (SA) node and papillary muscle preparations with donor animals. The blocking potencies of these compounds on the ,3-adrenergic effects on the cardiac functions were roughly divided in those of propranolol and of pindolol, and also in two groups on the difference of presence or absence of sympathomimetic effect. In this paper, two newly synthesized compounds were compared with the potencies of pindolol and propranolol.
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The isolated SA node and papillary muscle preparations were perfused at 100 mm Hg with the arterial blood conducted from the carotid artery of a heparinized donor dog by the aid of a peristaltic pump. The experimental setup of these preparations have been described in detail in previous papers (4, 5) . Drugs used were as follows: l-norepinephrine, dl propranolol hydrochloride, dl-pindolol, dl-5(3-tent-butylamino-2-hydroxy) propoxy-3,4 dihydrocarhostyril hydrochloride (OPC 1085, Otstika) (6) and dl-2,3-cis-1,2,3,4-tetrahydro 5-(2-hydroxy-3-tert-butylamino)propoxy-2,3-naphthalendiol (SQ 11725, Squibb) (7). All drugs were injected i.a. with microsyringes in volumes of 10-30 it for 4 sec.
Norepinephrine was used as an agonist in doses of 0.1 to 1 nmol. Norepinephrine was given 1 min after the administration of the antagonist and every 10 min successively until complete recovery from the ~3-adrenergic blocking effect. OPC 1085 showed a sympathomi metic response like pindolol, but its f3-adrenergic blocking effect was more long-lasting and in doses sufficient to block completely the chronotropic and inotropic responses to 0.3-1 nmol of norepinephrine, its effect persisted over 2 hours. SQ 11725 had practically no sympathomimetic effect, and its blocking effect disappeared within a period of one hour even in doses for inducing a complete blocking activity to 0.3-1 nmol of norepinephrine, which was shorter than that of propranolol. Dose-effect curves for these compounds to block the effect of norepinephrine in the SA node preparation are shown in Fig. 1 and those in the papillary muscle preparation in Fig. 2 . The potencies of these compounds at the peak effect were as follows: OPC 1085>.pindolol=SQ 11725>propranolol.
